BPH: a present and future perspective on health impact

Similar documents
VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

The Hallmarks of BPH Progression and Risk Factors

The Enlarged Prostate Symptoms, Diagnosis and Treatment

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Therapeutic Strategies for Managing BPH Progression

10th anniversary of 1st validated CaPspecific

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

Can men with prostates sized 80 ml or larger be managed conservatively?

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran

BPH: Social Impact and Patient s Perspective

Abstract. Key words Trial without catheter, Acute urinary retention, Benign prostatic hyperplasia, Introduction

The patient, your co-pilot in assessing LUTS

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

Chapter 4: Research and Future Directions

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Management of LUTS. Simon Woodhams February 2012

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Benign Prostatic Hyperplasia (BPH):

CONDUCT study A step further in changing treatment paradigm in BPH

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

Male LUTS, OAB, Sex: natural history. JR Sathiya

Treating BPH: Comparing Rezum UroLift and HoLEP

Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence.

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

The population of subjects which was statistically analyzed was the Intent-to-Treat population

Alpha antagonists from initial concept to routine clinical practice

The Journal of International Medical Research 2012; 40:

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?

Men s Lower Urinary Tract Symptoms Are Also Mental and Physical Sufferings for Their Spouses

Ejaculation. Emission. Ejection. Orgasm

ISSN: (Print) (Online) Journal homepage:

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

Benign Prostatic Hyperplasia and Enlarged Prostate Guidelines: How They Can Be Useful to Primary Care

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

Managing urinary morbidity after brachytherapy. Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Guideline for the primary care management of male lower urinary tract symptoms

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES

Male LUT/BPH. Current Issues and Unmet Needs

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

EAU GUIDELINES POCKET EDITION 3

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia

LUTS after TURP: How come and how to manage? Matthias Oelke

Elements for a Public Summary

Last Review Status/Date: December Summary

Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

Consensus Meeting for Asian-Pacific BPH Guideline

Low Incidence of Acute Urinary Retention in the General Male Population: TheTriumph Project

Alpha-BlockerTherapy Can Be Withdrawn in the Majority of Men Following Initial CombinationTherapy with the Dual 5a-Reductase Inhibitor Dutasteride

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study

Serum Prostate-Specific Antigen as a Predictor of Prostate Volume in the Community: The Krimpen Study

LONG-TERM SAFETY AND EFFICACY OF TAMSULOSIN FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

JMSCR Vol 05 Issue 07 Page July 2017

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

Title of Research Thesis:

INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE

Chapter 16 URINARY, SEXUAL AND REPRODUCTIVE IMPAIRMENT

Chapter 3: Results of the Treatment Outcomes Analyses

APPENDIX CLINICAL INPUT RESPONSES

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial

Single Technology Appraisal (STA) Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia

Prostatic Urethral Lift

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

FEP Medical Policy Manual

BPH with persistently elevated PSA 아주대학교김선일

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

FEP Medical Policy Manual

Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey

Original Article - Sexual Dysfunction

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Department of Urology, Cochin hospital Paris Descartes University

Hyoung Woo Kim, Dae Geun Moon, Hyun Min Kim, Jong Ho Hwang, Soon Chan Kim, Sam Geuk Nam, Jun Tag Park

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4.

What can the primary care physician do? Brian W. Ellis

Office Management of Benign Prostatic Enlargement

Wednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

Chapter 3: Results of the Treatment Outcomes Analyses

Recommended drug treatment of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

Subject: Temporary Prostatic Stent and Prostatic Urethral Lift

Transcription:

BPH: a present and future perspective on health impact Burden of disease in men with moderate LUTS Dalibor Pacík This presentation is financially supported by GlaxoSmithKline. CZ/DUTT/0019/12

Men with moderate LUTS due to BPH may experience a substantial health burden Today Tomorrow Bother Interference with daily activities Sexual dysfunction Worry Impact on physical and mental health Impact on personal relationships Potential BPH progression raises the prospect of additional adverse impact on quality of life through worsening of symptoms, as well as AUR and the need for surgery 2

Pharmacotherapy of BPH does not save life but can increase its quality.

LUTS associated with BPH are reported to impact a patient s activities of daily living % of men reporting that urinary symptoms interfered with activities of daily living at least some of the time during the past month Garraway WM et al. Br J Gen Pract 1993;43:318 321 4

One of the most bothersome symptoms in men with LUTS suggesting BPH is nocturia Nocturia may have a considerable adverse influence on QoL through sleep fragmentation Nocturia is cited as the most frequent cause of disturbed sleep continuity in older men Impaired sleep can have profound adverse consequences for somatic and mental health Abrams P. Eur Urol Supp 2005;3:1 7 Bonnet M H, Arand DL. Sleep Med Rev 2003;7:297 310 5

Sleep fragmentation and deprivation associated with nocturia can have a serious impact on health in the short and the long term Short-term Long-term Increased daytime sleepiness/reduced daytime alertness Longer reaction time Reduced daytime energy Reduced psychomotor performance Reduced concentration Depression Increased susceptibility to somatic disease Increased risk of cardiovascular disease Increased risk of car accidents and/or falls with fractures Institutionalisation Death Abrams P. Eur Urol Supp 2005;3:1 7 Bonnet M H, Arand DL. Sleep Med Rev 2003;7:297 310 6

Impact of BPH on HRQoL reflects severity of symptoms Mild symptoms Bother of urinary symptoms Interference with daily activities Worry about urologic disease Moderate-to-severe symptoms Bother of urinary symptoms Interference with daily activities Worry about urologic disease 4 6-fold worsening 1 4 6-fold worsening 1 2-fold worsening 1 1. Girman C et al. Urology 1994;44:825 31 7

Health-Related QoL Score (Age-Adjusted Means)* Impact of BPH on HRQoL reflects severity of symptoms Impact of bother begins with moderate symptoms LUTS Impact of interference begins with moderate symptoms Scale: 0 1 (health status: 0=best; 1=worst) *Higher scores indicate worse health status for all measures Girman C et al. Urology 1998; 51: 428 36 8

Reduction in QoL is much greater in patients with moderate-to-severe LUTS than in those with mild Men with moderate-to-severe LUTS and Enlarged Prostate were significantly more likely than those with mild symptoms to consider their prostate condition to have reduced their QoL (p<0.05) Roehrborn CG et al. Prostate Cancer Prostatic Dis 2006;9:30 4 9

The presence and severity of LUTS are risk factors for sexual dysfunction

The presence and severity of LUTS are risk factors for sexual dysfunction Sexual activity is common in a majority of men aged 50 80 years and is an important component of quality of life Men with moderate-to-severe LUTS are at increased risk for Erectile dysfunction Ejaculatory dysfunction Hypoactive desire Rosen R et al. Eur Urol 2003;44:637 49 Rosen R et al. Eur Urol 2005;47:824 837 11

Incidence (%) Erection problems are strongly associated with LUTS severity Effect of LUTS severity Effect of LUTS severity Effect of LUTS severity Age effect Rosen R et al. Eur Urol 2003; 44(6):637-49 50 59 years 60 69 years 70 79 years Rosen R et al. Eur Urol 2003;44:637 49 12

Average number of sexual activities per month Reduced sexual activity is strongly associated with LUTS severity Effect of LUTS severity Effect of LUTS severity Effect of LUTS severity Age effect Rosen R et al. Eur Urol 2003; 44(6):637-49 50 59 years 60 69 years 70 79 years Rosen R et al. Eur Urol 2003;44:637 49 13

Impaired sexual function is associated with reduced quality of life Rosen et al Sexual activity is common in a majority of men over age 50 and is an important component of overall quality of life. Because the inability to function sexually can erode an individual s sense of self-esteem and lead to emotional and marital tension, it is not surprising to find that QOL is diminished in men with erectile dysfunction. Althof Fugl-Meyer et al Using factor analytic technique, satisfaction with sexual life was found to be a powerful predictor for satisfaction with life as a whole. Rosen R et al. Eur Urol 2003;44:637 49 Althof SE. Urology 2002;59(6):803 810 Fugl-Meyer AR et al. Int J Impotence Res 1997;9:141 148 14

Partners of men with LUTS due to BPH also experience significant morbidity due to their husband s condition

Partners of men with LUTS due to BPH also experience significant morbidity due to their husband s condition Factors mainly affecting partner s QoL Psychological burden Inadequate sex life Sleep disturbance Disruption in social life* Inability to take care of essential tasks inside and outside the house Fear of prostater cancer Fear of surgery *Significantly correlated with partner s IPSS Mitropoulos D et al. Eur Urol 2002;41:240 45 16

The severity of LUTS can adversely impact important areas of personal relationships Men Spouses with moderate-to-severe of men with enlarged symptoms prostate were also more more likely likely than than those their with husband mild to report symptoms specific to report relationship problems concerns in their as marriage a result of their husband s condition Roehrborn CG et al. Prostate Cancer Prostatic Dis 2006;9:30 4 17

BPH: the future perspective on health impact

Cumulative incidence of progression (%) 4-year cumulative incidence of clinical progression: MTOPS population 25 20 4-year cumulative incidence of clinical progression* = 17% 15 10 5 Disease course in placebo arm of MTOPS** highlights progressive nature of BPH 0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 Years from randomisation *Clinical progression defined as an increase above base line of 4 points in the AUA symptom score, acute urinary retention, urinary incontinence, renal insufficiency, or recurrent urinary tract infection **MTOPS = Medical Therapy of Prostatic Symptoms study McConnell JD et al. NEJM 2003;349:2387 98 19

Deterioration in symptoms is the most common manifestation of BPH progression 4.5 years mean follow up in MTOPS (Medical Therapy of Prostatic Symptoms study) McConnell JD et al. N Engl J Med 2003;349:2387 98 20

Most men with BPH worry about the potential long-term consequences of their disease Patient concerns with risk for AUR and need for surgery Emberton M et al. Int J Clin Pract 2008; 62: 18 26 21

Men with moderate/severe symptoms have greater risk of AUR - Olmsted County Study Relative risk of AUR (unadjusted) 3.2 relative risk of AUR for men with moderate/severe symptoms compared to 1.0 for those with mild symptoms 40 49 50 59 60 69 70 79 0 7 8+ >12 12 30 >30 Retrospective review of occurence in the subsequent 4 y Age (yrs) AUA-SI Qmax (ml/s) Prostate volume (ml) Jacobsen SJ et al. J Urol 1997;158:481 487 22

The impact of AUR highlights the benefit of reducing the risk of the event occurring Acute urinary retention Pain Pain Short term Financial cost Recurrent hospitalization Likelihood of subsequent surgery Long term Increased risk of complications versus elective procedures Risk for recurrent retention Thomas K et al. BJU Int 2005; 95: 72 761; Roehrborn C. Rev Urol 2005;7(suppl4):S31 S41; Choong S, Emberton M. BJU Int 2000;85:186 201 23

Potential for occurrence of adverse events as outcomes of surgical therapies Median frequency (%) AUA Practice Guidelines Committee. J Urol 2003;170:530 47 24

Summary Initially, the burden of disease in a man with BPH largely reflects the severity of his symptoms Men with moderate LUTS due to BPH may experience a substantial reduction in their quality of life across multiple dimensions In many men the progressive course of BPH raises the prospect of worsening symptoms, as well as AUR and the need for surgery AUR and the need for surgery are of concern to the majority of men with BPH In the short term AUR may result in pain and the need for hospitalization A significant proportion of men presenting with AUR will ultimately require surgery, and the risk of poor outcomes is increased versus elective procedures BPH-related surgery is associated with risk for adverse events 25

Burden of disease in men with moderate LUTS Burden of BPH TODAY TOMORROW Reflects symptom severity and HRQoL impact Reflects disease progression 26

What is the prevalence of BPH in men s fifth decade? 1. 20% 2. 40% 3. 60% CZ/DUTT/0019a/12

Case Report

White male 68 ys old Admitted to Internal Disease Dpt Flatness, fatigue, nausea, sickness, dyspnoea gradually progressing during last several months No serious LUTS, last weeks frequency and sometimes incontinence History uneventful, Surgery for right inguinal hernia 5 ys ago Clinical status signs of pulmonary edema Laboratory findings: kreatinin 582, urea 22,8, K 6,1, mild anemia

Because of elevated kreatinin and K provided dialysis Consequently urological consultation US bilateral hydronephrosis, full bladder with large prostate TRUS prostate 150 ml PSA 9,8 ng/ml F/T 44%

Introduced urinary catheter, residual urine 800 ml, hydronephrosis disappeared Normalization urea, kreatinin Surgery open transvesical prostatectomy 4 weeks later. Pathology report: BPH

BPH several acute indications for surgery, rare cases jeopardizing life This case yes (renal insufficiency, cardiac complications, sepsis ) Prevention: periodic follow up, medication when symptoms, signs of progression, prevention of progression

Thank you for your attention